Literature DB >> 27481244

Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune Response.

Afshin Zariri1, Joep Beskers2, Bas van de Waterbeemd3, Hendrik Jan Hamstra2, Tim H E Bindels3, Elly van Riet3, Jos P M van Putten4, Peter van der Ley3.   

Abstract

Meningococcal outer membrane vesicles (OMVs) have been extensively investigated and successfully implemented as vaccines. They contain pathogen-associated molecular patterns, including lipopolysaccharide (LPS), capable of triggering innate immunity. However, Neisseria meningitidis contains an extremely potent hexa-acylated LPS, leading to adverse effects when its OMVs are applied as vaccines. To create safe OMV vaccines, detergent treatment is generally used to reduce the LPS content. While effective, this method also leads to loss of protective antigens such as lipoproteins. Alternatively, genetic modification of LPS can reduce its toxicity. In the present study, we have compared the effects of standard OMV isolation methods using detergent or EDTA with those of genetic modifications of LPS to yield a penta-acylated lipid A (lpxL1 and pagL) on the in vitro induction of innate immune responses. The use of detergent decreased both Toll-like receptor 4 (TLR4) and TLR2 activation by OMVs, while the LPS modifications reduced only TLR4 activation. Mutational removal of PorB or lipoprotein factor H binding protein (fHbp), two proteins known to trigger TLR2 signaling, had no effect, indicating that multiple TLR2 ligands are removed by detergent treatment. Detergent-treated OMVs and lpxL1 OMVs showed similar reductions of cytokine profiles in the human monocytic cell line MM6 and human dendritic cells (DCs). OMVs with the alternative penta-acylated LPS structure obtained after PagL-mediated deacylation showed reduced induction of proinflammatory cytokines interleukin-6 (IL-6) and IL-1β but not of IP-10, a typical TRIF-dependent chemokine. Taken together, these data show that lipid A modification can be used to obtain OMVs with reduced activation of innate immunity, similar to what is found after detergent treatment.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27481244      PMCID: PMC5038073          DOI: 10.1128/IAI.00635-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Outer membrane vesicle production by Escherichia coli is independent of membrane instability.

Authors:  Amanda J McBroom; Alexandra P Johnson; Sreekanth Vemulapalli; Meta J Kuehn
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

2.  Isolation of Neisseria meningitidis mutants deficient in class 1 (porA) and class 3 (porB) outer membrane proteins.

Authors:  J Tommassen; P Vermeij; M Struyvé; R Benz; J T Poolman
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

3.  Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria.

Authors:  G L Dixon; P J Newton; B M Chain; D Katz; S R Andersen; S Wong; P van der Ley; N Klein; R E Callard
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Expression of the lipopolysaccharide-modifying enzymes PagP and PagL modulates the endotoxic activity of Bordetella pertussis.

Authors:  Jeroen Geurtsen; Liana Steeghs; Hendrik-Jan Hamstra; Jan Ten Hove; Alex de Haan; Betsy Kuipers; Jan Tommassen; Peter van der Ley
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

5.  Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.

Authors:  W D Zollinger; R E Mandrell; J M Griffiss; P Altieri; S Berman
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

6.  Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent.

Authors:  Theresa E Singleton; Paola Massari; Lee M Wetzler
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

7.  Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine.

Authors:  Jo Anne Welsch; Raffaella Rossi; Maurizio Comanducci; Dan M Granoff
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

8.  Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba.

Authors:  G V Sierra; H C Campa; N M Varcacel; I L Garcia; P L Izquierdo; P F Sotolongo; G V Casanueva; C O Rico; C R Rodriguez; M H Terry
Journal:  NIPH Ann       Date:  1991-12

9.  Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis.

Authors:  Bas van de Waterbeemd; Gijsbert Zomer; Patricia Kaaijk; Nicole Ruiterkamp; René H Wijffels; Germie P J M van den Dobbelsteen; Leo A van der Pol
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

10.  Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response.

Authors:  Amanda J McBroom; Meta J Kuehn
Journal:  Mol Microbiol       Date:  2006-12-05       Impact factor: 3.501

View more
  6 in total

Review 1.  Bacterial outer membrane vesicle-based cancer nanovaccines.

Authors:  Xiaoyu Gao; Qingqing Feng; Jing Wang; Xiao Zhao
Journal:  Cancer Biol Med       Date:  2022-09-23       Impact factor: 5.347

Review 2.  The complex, bidirectional role of extracellular vesicles in infection.

Authors:  Joni Renee White; Priscila Dauros-Singorenko; Jiwon Hong; Frédérique Vanholsbeeck; Anthony Phillips; Simon Swift
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

Review 3.  The Therapeutic Benefit of Bacterial Membrane Vesicles.

Authors:  Natalie J Bitto; Maria Kaparakis-Liaskos
Journal:  Int J Mol Sci       Date:  2017-06-16       Impact factor: 5.923

Review 4.  Bacterial lipids: powerful modifiers of the innate immune response.

Authors:  Courtney E Chandler; Robert K Ernst
Journal:  F1000Res       Date:  2017-08-07

Review 5.  Pathogen-Derived Extracellular Vesicle-Associated Molecules That Affect the Host Immune System: An Overview.

Authors:  Marije E Kuipers; Cornelis H Hokke; Hermelijn H Smits; Esther N M Nolte-'t Hoen
Journal:  Front Microbiol       Date:  2018-09-12       Impact factor: 5.640

Review 6.  Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance.

Authors:  Zhuang Zhu; Fabio Antenucci; Kasper Rømer Villumsen; Anders Miki Bojesen
Journal:  mBio       Date:  2021-08-10       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.